SRD-001

DB25902InvestigationalGene Therapies

SRD-001 is a biologic drug. SRD-001 is under investigation in clinical trial NCT06224660 (Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy).

Code names: AAV1/SERCA2a · SRD-001

What you can answer from here — as of February 06, 2026

5Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of SRD-001, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account